post-add

Stryker Unveils MultiGen 2 RF Generator In India For Enhanced Chronic Pain Management

Coupled with the Venom Cannula and Electrode System, the MultiGen 2 provides the industry’s largest and least-invasive lesions in the shortest time, combining unparalleled reliability, efficiency, and control

Stryker, a leader in medical technologies, introduced its MultiGen 2 Radiofrequency (RF) Generator at the Interventional Radiofrequency Pain Conference held in Delhi. 

In a press statement on Thursday, the company informed that the advanced technology is designed to enhance RF ablation's efficiency, control, and reliability, a minimally invasive procedure offering lasting relief for individuals experiencing facet joint pain.

Facet joint pain, a common cause of chronic back pain, affects over 180 million people in India, with a prevalence rate of 19.3 per cent. Clinical research demonstrates that RF ablation can significantly alleviate pain severity and frequency for many patients for up to a year.

“The MultiGen 2 represents a significant advancement in radiofrequency ablation technology, offering physicians greater control and customisation for managing chronic pain with confidence,” stated Aman Rishi, VP and GM – India for Stryker. “With its enhanced efficiency and reliability, MultiGen 2 is set to transform the way facet joint pain is treated, delivering enduring relief to millions.”

The MultiGen 2 Generator boasts twice the power of industry standards, enabling quicker attainment of target temperatures with fewer errors. It features a single-button start, the ability to create strip lesions without electrode removal, and error resolution without procedural interruption, optimising time and scheduling. The system’s flexibility allows customisation based on individual patient needs and physician preferences.

Coupled with the Venom Cannula and Electrode System, the MultiGen 2 provides the industry’s largest and least-invasive lesions in the shortest time, combining unparalleled reliability, efficiency, and control, the  press statement read.

Also Read

Subscribe to our newsletter to get updates on our latest news